APLT
NASDAQ
$0.10
Applied Therapeutics Inc (APLT)
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to combat cardiovascular disease, galactosemia, and diabetes complications. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Target: $0.25 (+142.72%)
Market Cap
$15M
Beta (5Y)
1.06
Price Chart
Valuation
Market Cap$15M
P/S14.86
P/B7.72
Profitability
Total Revenue (TTM)$999K
Gross Profit (TTM)-$38M
EBITDA-$18M
Operating Margin-1797%
EPS-$0.12
Growth & Risk
EPS 5Y CAGR-51.04%
FCF 5Y CAGR+5.06%
Beta (5Y)1.06
Sharpe Ratio0.11